Improving Outcomes for Patients With Hormone Receptor–Positive Breast Cancer: Back to the Drawing Board-Reference-Cited by-同舟云学术

Improving Outcomes for Patients With Hormone Receptor–Positive Breast Cancer: Back to the Drawing Board

Published:2008-02-06 Issue:3 Volume:100 Page:159-161
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Ellis Matthew J.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/100/3/159/18074597/djm325.pdf

Reference14 articles.

1. Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer;Viale;J Natl Cancer Inst.,2008

2. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology;Bast;J Clin Oncol.,2001

3. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer;Paik;J Clin Oncol.,2006

4. HER2 and response to paclitaxel in node-positive breast cancer;Hayes;N Engl J Med.,2007

5. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal, node-positive, ER-positive breast cancer (S8814,INT0100);Albain

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-tumor activity of novel biisoquinoline derivatives against breast cancers;Bioorganic & Medicinal Chemistry Letters;2014-10

2. Role of the breast cancer surgeon in the personalized era;Breast Cancer Management;2013-05

3. Neoadjuvant Endocrine Therapy for Breast Cancer;Surgical Oncology Clinics of North America;2010-07

4. Neoadjuvant Endocrine Therapy for Breast Cancer;Breast Diseases: A Year Book Quarterly;2009-01

5. Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes;Breast Cancer Research;2008-10